The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Canonical pathway of nuclear factor κB activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis
Open accessAbstract
Nuclear factor κB (NF-κB) activation has been observed in human atherosclerotic plaques and is enhanced in unstable coronary plaques, but whether such activation has a protective or pathophysiological role remains to be determined. We addressed this question by developing a short-term culture system of cells isolated from human atherosclerotic tissue, allowing efficient gene transfer to directly investigate signaling pathways in human atherosclerosis. We found that NF-κB is activated in these cells and that this activity involves p65, p50, and c-Rel but not p52 or RelB. This NF-κB activation can be blocked by overexpression of IκBα or dominant-negative IκB kinase (IKK)-2 but not dominant-negative IKK-1 or NF-κB-inducing kinase, resulting in selective inhibition of inflammatory cytokines (tumor necrosis factor α, IL-6, and IL-8), tissue factor, and matrix metalloproteinases without affecting the antiinflammatory cytokine IL-10 or tissue inhibitor of matrix metalloproteinases. Our results demonstrate that the canonical pathway of NF-κB activation that involves p65, p50, c-Rel, and IKK-2 is activated in human atherosclerosis and results in selective up-regulation of major proinflammatory and prothrombotic mediators of the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chen, X., Xiu, M., Xing, J., Yu, S., Min, D., & Guo, F. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479439 · Cited by 5,742
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
Current Concepts of the Pathogenesis of the Acute Coronary Syndromes
Libby, P. (2001) · Circulation · doi:10.1161/01.cir.104.3.365 · Cited by 1,558
The IKK NF-κB system: a treasure trove for drug development
Karin, M., Yamamoto, Y., & Wang, Q. M. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1279 · Cited by 1,364
BRENNAN, F. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90430-3 · Cited by 1,129
Reduction of atherosclerosis in mice by inhibition of CD40 signalling
Mach, F., Schönbeck, U., Sukhova, G. K., Atkinson, E., & Libby, P. (1998) · Nature · doi:10.1038/28204 · Cited by 910
Protective Role of Interleukin-10 in Atherosclerosis
Mallat, Z., Besnard, S., Duriez, M., Deleuze, V., Emmanuel, F., Bureau, M. F., Soubrier, F., Esposito, B., Duez, H., Fievet, C., et al. (1999) · Circulation Research · doi:10.1161/01.res.85.8.e17 · Cited by 831
Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion.
Brand, K., Page, S., Rogler, G., Bartsch, A., Brandl, R., Knuechel, R., Page, M., Kaltschmidt, C., Baeuerle, P. A., & Neumeier, D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118598 · Cited by 798
Possible new role for NF-κB in the resolution of inflammation
Lawrence, T., Gilroy, D. W., Colville-Nash, P. R., & Willoughby, D. A. (2001) · Nature Medicine · doi:10.1038/nm1201-1291 · Cited by 749
Sato, H., & Seiki, M. (1993) · PubMed · Cited by 695
Development of anti-TNF therapy for rheumatoid arthritis
Feldmann, M. (2002) · Nature Reviews Immunology · doi:10.1038/nri802 · Cited by 673
Self-citationHajra, L., Evans, A. I., Chen, M., Hyduk, S. J., Collins, T., & Cybulsky, M. I. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.16.9052 · Cited by 574
The AP-1 site and MMP gene regulation: What is all the fuss about?
Benbow, U., & Brinckerhoff, C. E. (1997) · Matrix Biology · doi:10.1016/s0945-053x(97)90026-3 · Cited by 520
Pomerantz, J. L., & Baltimore, D. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00697-4 · Cited by 393
Bond, M. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00220-6 · Cited by 366
Kanters, E., Pasparakis, M., Gijbels, M. J. J., Vergouwe, M. N., Partouns-Hendriks, I., Fijneman, R. J. A., Clausen, B. E., Förster, I., Kockx, M. M., Rajewsky, K., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18580 · Cited by 340
Up-regulation of monocytic IL-10 by tumor necrosis factor-α and cAMP elevating drugs
Platzer, C., Meisel, C., Vogt, K., Platzer, M., & Volk, H.-D. (1995) · International Immunology · doi:10.1093/intimm/7.4.517 · Cited by 317
Foxwell, B., Browne, K., Bondeson, J., Clarke, C., de Martin, R., Brennan, F., & Feldmann, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8211 · Cited by 248
Self-citationKiriakidis, S., Andreakos, E., Monaco, C., Foxwell, B., Feldmann, M., & Paleolog, E. (2003) · Journal of Cell Science · doi:10.1242/jcs.00286 · Cited by 235
Self-citationNuclear factor κB: a potential therapeutic target in atherosclerosis and thrombosis
Monaco, C. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.11.038 · Cited by 227
Self-citationVincenti, M. P., Coon, C. I., & Brinckerhoff, C. E. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199811)41:11<1987::aid-art14>3.0.co;2-8 · Cited by 222
Bondeson, J., Foxwell, B., Brennan, F., & Feldmann, M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5668 · Cited by 207
Self-citationRole of nuclear factor‐kappa B in atherogenesis
Brand, K., Page, S., Walli, A., Neumeier, D., & Baeuerle, P. (1997) · Experimental Physiology · doi:10.1113/expphysiol.1997.sp004025 · Cited by 178
Chase, A. J., Bond, M., Crook, M. F., & Newby, A. C. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000015078.09208.92 · Cited by 167
Bondeson, J., Browne, K. A., Brennan, F. M., Foxwell, B. M. J., & Feldmann, M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.5.2939 · Cited by 154
Self-citationBondeson, J., Browne, K. A., Brennan, F. M., Foxwell, B. M. J., & Feldmann, M. (1999) · PubMed · Cited by 149
Self-citationYoshimura, S., Morishita, R., Hayashi, K., Yamamoto, K., Nakagami, H., Kaneda, Y., Sakai, N., & Ogihara, T. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301566 · Cited by 121
Kanters, E., Gijbels, M. J., van der Made, I., Vergouwe, M. N., Heeringa, P., Kraal, G., Hofker, M. H., & de Winther, M. P. J. (2003) · Blood · doi:10.1182/blood-2003-05-1450 · Cited by 111
Breuss, J. M., Cejna, M., Bergmeister, H., Kadl, A., Baumgartl, G., Steurer, S. A., Xu, Z., Koshelnick, Y., Lipp, J., de Martin, R., et al. (2002) · Circulation · doi:10.1161/hc0502.102966 · Cited by 97
Wilson, S. H., Best, P. J. M., Edwards, W. D., Holmes, D. R., Carlson, P. J., Celermajer, D. S., & Lerman, A. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00546-9 · Cited by 89
Smith, C., Andreakos, E., Crawley, J. B., Brennan, F. M., Feldmann, M., & Foxwell, B. M. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.10.5895 · Cited by 87
Self-citationCiesielski, C. J., Andreakos, E., Foxwell, B. M. J., & Feldmann, M. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200207)32:7<2037::aid-immu2037>3.0.co;2-i · Cited by 76
Self-citationAndreakos, E., Smith, C., Kiriakidis, S., Monaco, C. G., de Martin, R., Brennan, F. M., Paleolog, E. M., Feldmann, M., & Foxwell, B. M. J. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11044 · Cited by 67
Self-citationMonaco, C. G., Andreakos, E., Young, S., Feldmann, M., & Paleolog, E. M. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.4.659 · Cited by 52
Self-citationZuckerbraun, B. S., McCloskey, C. A., Mahidhara, R. S., Kim, P. K. M., Taylor, B. S., & Tzeng, E. (2003) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(03)00427-0 · Cited by 48
Conron, M., Andreakos, E., Pantelidis, P., Smith, C., Beynon, H. L. C., du Bois, R. M., & Foxwell, B. M. J. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.7.2107058 · Cited by 18
Self-citation
Cited by
NF-κB signaling in inflammation
Liu, T., Zhang, L., Joo, D., & Sun, S.-C. (2017) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2017.23 · Cited by 8,791
The Nuclear Factor NF- B Pathway in Inflammation
Lawrence, T. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001651 · Cited by 4,898
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Tedgui, A., & Mallat, Z. (2006) · Physiological Reviews · doi:10.1152/physrev.00024.2005 · Cited by 1,701
INFLAMMATION AND ATHEROSCLEROSIS
Hansson, G. K., Robertson, A.-K. L., & Söderberg-Nauclér, C. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100100 · Cited by 1,046
Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches
Park, M., & Hong, J. (2016) · Cells · doi:10.3390/cells5020015 · Cited by 627
Metadata
- Authors
- Monaco, C., Andreakos, E., Kiriakidis, S., Mauri, C., Bicknell, C., Foxwell, B., Cheshire, N., Paleolog, E., & Feldmann, M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2004-04-02
- Volume
- 101
- Issue
- 15
- Pages
- 5634-5639
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2032766057
- Cited by
- 348
- References
- 36
- FWCI
- 4.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.